Natural killer cell activity in patients with hepatocellular carcinoma: A new prognostic indicator after hepatectomy

Cancer

Volumn 83, Issue 1, 1998, Pages 58-63

  Taketomi, Akinobu ^a   Shimada, Mitsuo ^b   Shirabe, Ken ^b   Kajiyama, Kiyoshi ^b   Gion, Tomonobu ^b   Sugimachi, Keizo ^b  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Natural killer cell activity; Prognosis

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE;

EID: 0032127376     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<58::AID-CNCR8>3.0.CO;2-A     Document Type: Article

References (24)

1. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996;77:1226-43.
2. Cook JL, Lewis AM Jr. Immunological surveillance against DNA virus-transformed cells: correlations between natural killer cell cytolytic competence and tumor susceptibility of athymic rodents. J Virol 1987;61:2155-61.
3. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR. Role of NK cells in tumor growth and metastasis in beige mice. Nature 1980;284:622-4.
4. Schants SP, Campbell BH, Guillamondegul OM. Pharyngeal carcinoma and natural killer cell activity. Am J Surg 1986; 152:467-74.
5. Yamaguchi Y, Takashima I, Funakoshi M, Kawami H, Toge T. Defective natural killer activity in gastric cancer patients: possible involvement of suppressor factor receptor. In Vivo 1994;8:279-83.
6. LeFever AV, Funahashi A. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma. Cancer Res 1991;51:5596-601.
7. Cunningham-Rundles S, Flippa DA, Braun DW, Antonelli P, Ashikari H. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells of breast cancer in women. J Natl Cancer Inst 1981;67:585-90.
8. Tartter PA, Steinberg B, Barron DM, Martinelli G. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 1987;122:1264-8.
9. Nakajima H, Mizushima N, Kanai K. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver. Jpn J Clin Oncol 1987;17:327-32.
10. Chung WL, Liu HW, Chang WY. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Cancer 1990;65:926-30.
11. Oshimi K, Oshimi Y, Satake M, Mizoguchi H. Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes. J Exp Med 1985;162:472-86.
12. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996;111:720-6.
13. Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells. Clin Exp Immunol 1987;68:348-56.
14. Johnson PJ, Williams R. Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 1987;5:140-7.
15. Son K, Kew M, Rabson AR. Depressed natural killer cell activity in patients with hepatocellular carcinoma: in vivo effects of interferon and levamisole. Cancer 1982;50:2820-5.
16. Ortaldo JR, Hiserodt JC. Mechanisms of target killing by natural killer cells. Curr Opin Immunol 1989;2:39-42.
17. Yokoyama WM. Natural killer cell receptors. Curr Opin Immunol 1995;7:110-20.
18. Rabinowich H, Herberman RB, Whiteside TL. Differential effects of IL-12 and IL-2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell Immunol 1993;152:481-91.
19. Sullivan JL, Bryon KS, Brewster FE, Purtilo DT. Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 1980;210:543-5.
20. Gui XE, Charles R, Rinaldo JR, Monto HO. Natural killer cell activity in renal transplant recipients receiving cyclosporine. Infect Immunol 1983;41:965-70.
21. Pollock RE, Lotzova E, Stanford SD. Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. Arch Surg 1991;126:338-42.
22. Pollock RE, Lotzova E, Stanford SD. Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors. Cancer 1992;70:2192-202.
23. Lee CS, Lee FZ. Natural killer cell activity in hepatocellular carcinoma patients. J Formason Med Assoc 1989;88:478-82.
24. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, Notti I, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 1996;82:492-7.